Recombinant Human ADAMTS19, N-His

Description of Recombinant Human ADAMTS19, N-His

Introduction

Recombinant Human ADAMTS19 is a protein that plays a crucial role in various biological processes, including tissue development, wound healing, and immune response. This protein is a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) family, which is known for its role in extracellular matrix remodeling and proteolysis. In this article, we will delve into the structure, activity, and applications of Recombinant Human ADAMTS19.

Structure of Recombinant Human ADAMTS19

Recombinant Human ADAMTS19 is a 1057 amino acid protein with a predicted molecular weight of approximately 118 kDa. It contains a signal peptide, a pro-domain, a metalloproteinase domain, a disintegrin-like domain, a thrombospondin type-1 motif, a cysteine-rich domain, a spacer domain, and a cysteine-rich domain at the C-terminus. The metalloproteinase domain is responsible for the proteolytic activity of ADAMTS19, while the disintegrin-like domain is involved in cell adhesion and signaling. The thrombospondin type-1 motif is known to interact with extracellular matrix proteins, and the cysteine-rich domains are involved in protein-protein interactions.

Activity of Recombinant Human ADAMTS19

Recombinant Human ADAMTS19 is a secreted protein that is expressed in various tissues, including the heart, lung, and skeletal muscle. It is known to have proteolytic activity against various substrates, including aggrecan, versican, and fibronectin. This activity is essential for the remodeling and maintenance of the extracellular matrix, which is crucial for tissue development and repair. Additionally, ADAMTS19 has been shown to play a role in the regulation of immune response by cleaving cytokines and chemokines, thereby modulating their activity.

Applications of Recombinant Human ADAMTS19

Recombinant Human ADAMTS19 has various applications in both research and therapeutic settings. Its proteolytic activity makes it a valuable tool for studying the extracellular matrix and its role in tissue development and repair. It has also been used in wound healing studies, as it is known to promote cell migration and proliferation. In terms of therapeutics, ADAMTS19 has been investigated as a potential treatment for diseases involving excessive extracellular matrix deposition, such as fibrosis. Additionally, its role in immune regulation makes it a potential target for the treatment of autoimmune diseases.

Recombinant Protein Production

Recombinant Human ADAMTS19 can be produced using various expression systems, including mammalian cells, insect cells, and bacterial cells. The choice of expression system depends on the desired post-translational modifications and yield of the protein. For example, mammalian cells are preferred for proteins that require complex glycosylation, while bacterial cells are more suitable for high yield production. The recombinant protein can then be purified using various chromatography techniques, such as affinity chromatography and size-exclusion chromatography.

Antigen for Antibody Production

Recombinant Human ADAMTS19 can also be used as an antigen for the production of specific antibodies. These antibodies can be used for various applications, such as western blotting, immunohistochemistry, and enzyme-linked immunosorbent assays (ELISAs). They can also be used for immunoprecipitation and co-immunoprecipitation studies to identify protein-protein interactions involving ADAMTS19.

Conclusion

In summary, Recombinant Human ADAMTS19 is a multi-domain protein with proteolytic activity and a crucial role in tissue development, wound healing, and immune regulation. Its structure and activity make it a valuable tool